- Home
- MTNB vs ZBAI Comparison
MTNB vs ZBAI Comparison
Compare MTNB & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- ZBAI
- Stock Information
- Founded
- MTNB 2013
- ZBAI 2015
- Country
- MTNB United States
- ZBAI United States
- Employees
- MTNB N/A
- ZBAI N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- ZBAI Professional Services
- Sector
- MTNB Health Care
- ZBAI Consumer Discretionary
- Exchange
- MTNB Nasdaq
- ZBAI Nasdaq
- Market Cap
- MTNB 10.8M
- ZBAI 11.3M
- IPO Year
- MTNB N/A
- ZBAI N/A
- Fundamental
- Price
- MTNB $1.16
- ZBAI $7.80
- Analyst Decision
- MTNB
- ZBAI
- Analyst Count
- MTNB 0
- ZBAI 0
- Target Price
- MTNB N/A
- ZBAI N/A
- AVG Volume (30 Days)
- MTNB 17.8K
- ZBAI 9.8K
- Earning Date
- MTNB 11-10-2025
- ZBAI 12-18-2025
- Dividend Yield
- MTNB N/A
- ZBAI N/A
- EPS Growth
- MTNB N/A
- ZBAI N/A
- EPS
- MTNB N/A
- ZBAI N/A
- Revenue
- MTNB N/A
- ZBAI $720,000.00
- Revenue This Year
- MTNB N/A
- ZBAI N/A
- Revenue Next Year
- MTNB N/A
- ZBAI N/A
- P/E Ratio
- MTNB N/A
- ZBAI N/A
- Revenue Growth
- MTNB N/A
- ZBAI 44.00
- 52 Week Low
- MTNB $0.47
- ZBAI $4.83
- 52 Week High
- MTNB $3.09
- ZBAI $45.00
- Technical
- Relative Strength Index (RSI)
- MTNB 34.72
- ZBAI 36.20
- Support Level
- MTNB $1.17
- ZBAI $6.77
- Resistance Level
- MTNB $1.30
- ZBAI $8.60
- Average True Range (ATR)
- MTNB 0.08
- ZBAI 0.46
- MACD
- MTNB 0.00
- ZBAI -0.18
- Stochastic Oscillator
- MTNB 17.27
- ZBAI 7.00
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.